Education
About Us
Working with TipRanks
Follow Us
Lumos Diagnostics Holdings Ltd. (AU:LDX)
ASX:LDX
Total Valuation
Lumos Diagnostics Holdings Ltd. has a market cap or net worth of AU$169.25M. The enterprise value is AU$27.88M.
Market CapAU$169.25M
Enterprise ValueAU$27.88M
Share Statistics
Lumos Diagnostics Holdings Ltd. has 787,216,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding787,216,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lumos Diagnostics Holdings Ltd.’s return on equity (ROE) is -1.17 and return on invested capital (ROIC) is -59.67%.
Return on Equity (ROE)-1.17
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-59.67%
Return on Capital Employed (ROCE)-0.65
Revenue Per Employee10.00T>
Profits Per Employee―
Employee Count―
Asset Turnover0.60
Inventory Turnover8.82
Valuation Ratios
The current PE Ratio of Lumos Diagnostics Holdings Ltd. is ―. Lumos Diagnostics Holdings Ltd.’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.97
PB Ratio1.96
Price to Fair Value1.96
Price to FCF-1.29
Price to Operating Cash Flow-9.58
PEG Ratio0.04
Income Statement
In the last 12 months, Lumos Diagnostics Holdings Ltd. had revenue of 12.50M and earned -7.18M in profits. Earnings per share was -0.01.
Revenue12.50M
Gross Profit7.91M
Operating Income-7.84M
Pretax Income-7.18M
Net Income-7.18M
EBITDA-4.63M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -9.33M and capital expenditures -53.00K, giving a free cash flow of -9.39M billion.
Operating Cash Flow-9.33M
Free Cash Flow-9.39M
Free Cash Flow per Share-0.01
Dividends & Yields
Lumos Diagnostics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.33
52-Week Price Change600.00%
50-Day Moving Average0.21
200-Day Moving Average0.10
Relative Strength Index (RSI)65.30
Average Volume (3m)5.63M
Important Dates
Lumos Diagnostics Holdings Ltd. upcoming earnings date is Feb 23, 2026, After Close (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateFeb 23, 2026
Ex-Dividend Date―
Financial Position
Lumos Diagnostics Holdings Ltd. as a current ratio of 0.74, with Debt / Equity ratio of 113.45%
Current Ratio0.74
Quick Ratio0.68
Debt to Market Cap0.00
Net Debt to EBITDA-1.09
Interest Coverage Ratio-392.10
Taxes
In the past 12 months, Lumos Diagnostics Holdings Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lumos Diagnostics Holdings Ltd. EV to EBITDA ratio is -3.69, with an EV/FCF ratio of -1.82.
EV to Sales1.37
EV to EBITDA-3.69
EV to Free Cash Flow-1.82
EV to Operating Cash Flow-1.83
Balance Sheet
Lumos Diagnostics Holdings Ltd. has AU$1.96M in cash and marketable securities with AU$6.99M in debt, giving a net cash position of -AU$5.03M billion.
Cash & Marketable SecuritiesAU$1.96M
Total DebtAU$6.99M
Net Cash-AU$5.03M
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share>-AU$0.01
Margins
Gross margin is 61.93%, with operating margin of -62.74%, and net profit margin of -57.46%.
Gross Margin61.93%
Operating Margin-62.74%
Pretax Margin-57.46%
Net Profit Margin-57.46%
EBITDA Margin-37.08%
EBIT Margin-57.30%
Analyst Forecast
The average price target for Lumos Diagnostics Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast12.96%
EPS Growth Forecast40.81%